Recent Updates
Recently added Catalysts
LH Positive Sentiment Score: 70/100

Document FOR IMMEDIATE RELEASE Labcorp Contacts Investors Christin O'Donnell - 336-436-5076 Investor Labcorp.com Media Kimbrel Arculeo - 336-436-8263 Media Labcorp.com Labcorp to Speak at the 44th Annual William Blair Gr

Tuesday, May 28, 2024 1 min read
Key Takeaway: Labcorp (NYSE LH) announced that its executive management team will present at the 44th Annual William Blair Growth Stock Conference on June 4, 2024. The company is recognized as a leader in innovative laboratory services, supporting healthcare professionals and patients globally. Labcorp's contributions include providing insights that have supported a significant percentage of new FDA drug approvals and conducting millions of tests worldwide. This event highlights Labcorp's ongoing commitment to advancing health and science.

Market Sentiment Analysis

POSITIVE FACTORS

  • Labcorp is a global leader in laboratory services.
  • The company supported 84% of FDA drug approvals in 2023.
  • Labcorp aims to improve health through advanced diagnostics.

Full Press Release Details

Investors Christin O'Donnell - 336-436-5076
Investor Labcorp.com
Media Kimbrel Arculeo - 336-436-8263
Labcorp to Speak at the 44th Annual William Blair Growth Stock Conference
BURLINGTON, N.C., May 28, 2024 - Labcorp (NYSE LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a presentation at the 44th Annual William Blair Growth Stock Conference on Tuesday, June 4 at 2 00 p.m. (CT).
Labcorp (NYSE LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 67,000 employees serve clients in approximately 100 countries, provided support for 84% of the new drugs and therapeutic products approved in 2023 by the FDA, and performed more than 600 million tests for patients around the world. Learn more about us at www.Labcorp.com.

Frequently Asked Questions

When will Labcorp speak at the William Blair Growth Stock Conference?

Labcorp will present at the conference on June 4 at 2:00 p.m. (CT).

How many employees does Labcorp have?

Labcorp employs more than 67,000 individuals globally.

How many tests did Labcorp perform in 2023?

Labcorp conducted over 600 million tests for patients in 2023.

What role does Labcorp play in drug development?

Labcorp supported 84% of new FDA-approved drugs in 2023.

Tags: LH Viatris Investor Conferences Healthcare Labcorp growth stock conference FDA approvals laboratory services NYSE LH
Last updated: May 28, 2024